Scientists test new Drug's hidden effects on your daily coffee and medicine
NCT ID NCT06821698
Summary
This study aimed to understand how an experimental drug called KP-001 might interact with other common substances in the body. Researchers gave KP-001 to 38 healthy volunteers along with a cholesterol medication (rosuvastatin) and caffeine to see if it changed how these substances were processed. The goal was to gather basic safety and interaction data to inform future research, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Parexel International Early Phase Clinical Unit
Glendale, California, 91206, United States
Conditions
Explore the condition pages connected to this study.